Phone Calls to Retain Research Participants and Determinants of Reachability in an African Setting: Observational Study

Melvin Draaijer, Samanta Tresha Lalla-Edward, Willem Daniel Francois Venter, Alinda Vos, Melvin Draaijer, Samanta Tresha Lalla-Edward, Willem Daniel Francois Venter, Alinda Vos

Abstract

Background: Long-term retention of research participants in studies is challenging. In research in sub-Saharan Africa, phone calls are the most frequently used method to distantly engage with participants.

Objective: We aimed to get insight into the effectiveness of phone calls to retain contact with participants and evaluated determinants of reachability.

Methods: A cross-sectional study was performed using the databases of two randomized controlled trials investigating different kinds of antiretroviral therapy in HIV-positive patients. One trial finished in 2018 (study 1), and the other finished in 2015 (study 2). A random sample size of 200 participants per study was obtained. There were up to 3 phone numbers available per participant collected during the studies. Participants received a maximum of 3 phone calls on every available number on different days and at different times. Voicemails were left, and emails sent wherever possible. We documented how many calls were answered, who answered, as well as after how many attempts participants were reached. To further increase our understanding of reachability, we conducted a short questionnaire assessing factors contributing to reachability. The study was approved by the Research Ethics Committee of the University of Witwatersrand, Johannesburg, South Africa (reference number M1811107).

Results: In our sample size of n=200 per study, study 1, with a median time of 11 months since the last visit at the research site, had a response rate of 70.5% (141/200) participants while study 2, with a median duration of 55 months since the last visit, had a response rate of 50.0% (100/200; P<.001). In study 1, 61.5% (123/200) of calls were answered directly by the participant while this was 36.0% (72/200) in study 2 (P=.003). The likelihood of reaching a participant decreased with time (odds ratio [OR] 0.73, 95% CI 0.63 to 0.84) for every year since the last face-to-face visit. Having more phone numbers per participant increased reachability (OR 2.32, 95% CI 1.24 to 4.36 for 2 phone numbers and OR 3.03, 95% CI 1.48 to 6.22 for 3 phone numbers compared with 1 number). A total of 141 of 241 reached participants responded to the questionnaire. Of the 93 participants who had changed phone numbers, 5% (50/93) had changed numbers because their phone was stolen. The most preferred method of being contacted was direct calling (128/141) with participants naming this method followed by WhatsApp (69/141).

Conclusions: Time since last visit and the number of phone numbers listed were the only determinants of reachability. Longer follow-up time is accompanied with a decrease in reachability by phone while more listed phone numbers increases the likelihood that someone can be reached.

Trial registration: ClinicalTrials.gov NCT02671383; https://ichgcp.net/clinical-trials-registry/NCT02671383 and ClinicalTrials.gov NCT02670772; https://ichgcp.net/clinical-trials-registry/NCT02670772.

Keywords: ART; HIV; South Africa; loss to follow-up; mobile phones; phone; retention.

Conflict of interest statement

Conflicts of Interest: None declared.

©Melvin Draaijer, Samanta Tresha Lalla-Edward, Willem Daniel Francois Venter, Alinda Vos. Originally published in JMIR Formative Research (http://formative.jmir.org), 30.09.2020.

Figures

Figure 1
Figure 1
Flowchart of sample selection.
Figure 2
Figure 2
Reachability comparison between study 1 and study 2.

References

    1. Mistiaen P, Poot E. Telephone follow-up, initiated by a hospital-based health professional, for postdischarge problems in patients discharged from hospital to home. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004510. doi: 10.1002/14651858.CD004510.pub3.
    1. Dudas V, Bookwalter T, Kerr KM, Pantilat SZ. The impact of follow-up telephone calls to patients after hospitalization. Am J Med. 2001 Dec 21;111(9B):26S–30S. doi: 10.1016/s0002-9343(01)00966-4.
    1. Chi BH, Stringer JSA. Mobile phones to improve HIV treatment adherence. Lancet. 2010 Nov 27;376(9755):1807–1808. doi: 10.1016/S0140-6736(10)62046-6.
    1. General Household Survey 2018. Pretoria: Statistics South Africa; 2018. [2020-09-05]. .
    1. Crankshaw T, Corless IB, Giddy J, Nicholas PK, Eichbaum Q, Butler LM. Exploring the patterns of use and the feasibility of using cellular phones for clinic appointment reminders and adherence messages in an antiretroviral treatment clinic, Durban, South Africa. AIDS Patient Care STDS. 2010 Nov;24(11):729–734. doi: 10.1089/apc.2010.0146.
    1. Saka B, Landoh DE, Patassi A, d'Almeida S, Singo A, Gessner BD, Pitché P. Loss of HIV-infected patients on potent antiretroviral therapy programs in Togo: risk factors and the fate of these patients. Pan Afr Med J. 2013;15(35) doi: 10.11604/pamj.2013.15.35.2198.
    1. Coly A, Kan Victor K, Dobe S, Agbo S, Nguessan J, Traore V. Factors associated with loss to follow-up status among ART patients in Cote d'Ivoire. USAID Health Care Improvement Project. 2014. [2020-09-05]. .
    1. Venter WDF, Moorhouse M, Sokhela S, Serenata C, Akpomiemie G, Qavi A, Mashabane N, Arulappan N, Sim JW, Sinxadi PZ, Wiesner L, Maharaj E, Wallis C, Boyles T, Ripin D, Stacey S, Chitauri G, Hill A. Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial. Lancet HIV. 2019 Jul;6(7):e428–e437. doi: 10.1016/S2352-3018(19)30081-5.
    1. Venter WDF, Kambugu A, Chersich MF, Becker S, Hill A, Arulappan N, Moorhouse M, Majam M, Akpomiemie G, Sokhela S, Poongulali S, Feldman C, Duncombe C, Ripin DHB, Vos A, Kumarasamy N. Efficacy and safety of tenofovir disoproxil fumarate versus low-dose stavudine over 96 weeks: a multicountry randomized, noninferiority trial. J Acquir Immune Defic Syndr. 2019 Feb 01;80(2):224–233. doi: 10.1097/QAI.0000000000001908.
    1. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377–381. doi: 10.1016/j.jbi.2008.08.010.
    1. Mberi MN, Kuonza LR, Dube NM, Nattey C, Manda S, Summers R. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study. BMC Health Serv Res. 2015 Jul 04;15:259. doi: 10.1186/s12913-015-0912-2.
    1. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007 Oct 16;4(10):e298. doi: 10.1371/journal.pmed.0040298.
    1. Mars M, Scott RE. WhatsApp in clinical practice: a literature review. Stud Health Technol Inform. 2016;231:82–90.
    1. Forrest JI, Wiens M, Kanters S, Nsanzimana S, Lester RT, Mills EJ. Mobile health applications for HIV prevention and care in Africa. Curr Opin HIV AIDS. 2015 Nov;10(6):464–471. doi: 10.1097/COH.0000000000000198.
    1. Hardy H, Kumar V, Doros G, Farmer E, Drainoni M, Rybin D, Myung D, Jackson J, Backman E, Stanic A, Skolnik PR. Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care STDS. 2011 Mar;25(3):153–161. doi: 10.1089/apc.2010.0006.

Source: PubMed

3
Abonner